Goodwill and Other Intangibles, Net

12 Months Ended

Dec. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

The following table summarizes changes in goodwill by reporting unit during the twelve months ended December 31, 2017 and 2016 (amounts in thousands):



	Home health reporting unit			Hospice reporting unit			Community- based reporting unit		Facility-based reporting unit			Total
Balance as of December 31, 2015	$	202,995		$	58,136		$	17,972	$	11,591		$	290,694
Goodwill from acquisitions	6,760			7,460			848		1,493			16,561
Goodwill related to noncontrolling interests	580			355			—		340			1,275
Goodwill related to prior period net working capital adjustments	504			(1,717		)	—		—			(1,213		)
Balance as of December 31, 2016	$	210,839		$	64,234		$	18,820	$	13,424		$	307,317
Goodwill from acquisitions	30,623			15,000			6,220		160			52,003
Goodwill related to noncontrolling interests	21,469			9,580			3,501		(141		)	34,409
Goodwill related to impairment on disposals	(1,470		)	—			—		—			(1,470		)
Goodwill related to prior year adjustments	(5		)	—			—		347			342
Balance as of December 31, 2017	$	261,456		$	88,814		$	28,541	$	13,790		$	392,601

The Company determined that there was no impairment for the goodwill of any reporting units as of December 31, 2017, 2016 and 2015 based on the Company's annual impairment testing; however, the Company did record $1.5 million of disposal of goodwill during the year ended December 31, 2017 due to the closure of underperforming locations. The amount of disposal of goodwill was determined using prices of comparable business in the market. This was recorded in impairment of intangibles and other on the Company's consolidated statements of income.

The Company performed an impairment analysis on its indefinite-lived intangible assets related to the Company's trade names, licenses and certificates of need and determined that it is not more likely than not that the fair values of the indefinite-lived intangible assets are less than its carrying amount as of November 30, 2017.

The following tables summarize the changes in intangible assets during the twelve months ended December 31, 2017 and 2016 (amounts in thousands):



	December 31, 2017
	Remaining useful life	Gross carrying amount		Accumulated amortization		Net carrying amount
Indefinite-lived assets:
Trade names	Indefinite	$	78,299	$	—	$	78,299



Certificates of need/licenses	Indefinite	53,493		—			53,493
Total		131,792		—			131,792
Amortizing assets:
Trade names	4 months – 10 years	10,127		(7,547		)	2,580
Non-compete agreements	2 months – 2 years	5,732		(5,494		)	238
Total		15,859		(13,041		)	2,818
Balance at December 31, 2017		$	147,651	$	(13,041	)	$	134,610



	December 31, 2016
	Remaining useful life	Gross carrying amount		Accumulated amortization			Net carrying amount
Indefinite-lived assets:
Trade names	Indefinite	$	64,672	$	—		$	64,672
Certificates of need/licenses	Indefinite	33,327		—			33,327
Total		$	97,999	$	—		$	97,999
Amortizing assets:
Trade names	8 months – 9 years	$	9,294	$	(5,991	)	$	3,303
Non-compete agreements	2 months – 3 years	5,681		(4,977		)	704
Total		14,975		(10,968		)	4,007
Balance at December 31, 2016		$	112,974	$	(10,968	)	$	102,006

Intangible assets of $88.1 million, net of accumulated amortization, related to the home health services segment, $32.0 million related to the hospice segment, $9.5 million related to the community-based services segment and $5.0 million related to the facility-based services segment as of December 31, 2017. Amortization for the years ended December 31, 2017, 2016 and 2015 was $2.1 million, $2.5 million and $1.9 million, respectively, which was recorded in general and administrative expenses.

The estimated intangible asset amortization expense for each of the five years subsequent to December 31, 2017 is as follows (amounts in thousands):



Year	Amortization amount
2018	$	1,467
2019	448
2020	236
2021	105
2022	100
Total	$	2,356

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details